CN100571737C - A kind of health care eye pastes - Google Patents
A kind of health care eye pastes Download PDFInfo
- Publication number
- CN100571737C CN100571737C CNB2007100726386A CN200710072638A CN100571737C CN 100571737 C CN100571737 C CN 100571737C CN B2007100726386 A CNB2007100726386 A CN B2007100726386A CN 200710072638 A CN200710072638 A CN 200710072638A CN 100571737 C CN100571737 C CN 100571737C
- Authority
- CN
- China
- Prior art keywords
- eye
- radix
- present
- effect
- health care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000036541 health Effects 0.000 title claims abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 27
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 27
- 241000628997 Flos Species 0.000 claims abstract description 21
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 12
- 244000293323 Cosmos caudatus Species 0.000 claims abstract description 12
- 235000005956 Cosmos caudatus Nutrition 0.000 claims abstract description 12
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 12
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 244000269722 Thea sinensis Species 0.000 claims abstract description 9
- 229910021538 borax Inorganic materials 0.000 claims abstract description 8
- 239000004328 sodium tetraborate Substances 0.000 claims abstract description 8
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 8
- 230000000694 effects Effects 0.000 abstract description 16
- 208000003464 asthenopia Diseases 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 208000003251 Pruritus Diseases 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 208000002193 Pain Diseases 0.000 description 9
- 239000000843 powder Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000201295 Euphrasia Species 0.000 description 4
- 206010047513 Vision blurred Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 208000030533 eye disease Diseases 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010015958 Eye pain Diseases 0.000 description 2
- 206010034960 Photophobia Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000010034 metabolic health Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a kind of health care eye pastes.Its prescription by weight by: Flos Chrysanthemi 1-6g, Radix Paeoniae Alba 1-6g, tea 1-5g, Margarita 0.5-4g, Radix Angelicae Dahuricae 0.5-3g, Cortex Phellodendri 0.5-4g, Fructus Jujubae 0.5-5g, Flos Carthami 0.5-4g, Rhizoma Chuanxiong 1-6g, Concha Haliotidis 0.5-4g, Radix Glycyrrhizae 0.5-4g, Borax 0.5-3g, Borneolum Syntheticum 0.5-3g, Mentholum 0.5-3g, propylene glycol 2-8g and glycerol 2-8g form.Reasonable recipe of the present invention, effect is unique, eyestrain who produces for excess eye-using and dry and astringent, disease such as itch, effect significantly can effectively be alleviated the eyestrain, promotes the ocular blood circulation, strengthens metabolism.
Description
(1) technical field
The present invention relates to eye Chinese medicine technology, be specifically related to a kind of eye health protection eye and paste.
(2) background technology
Along with the continuous quickening of rhythm of life and the universal use of computer, eye-care has become the problem that people pay close attention at present the most gradually, comprise that the eyes that various oculopathy cause are dry and astringent, itch, pain, swelling, shed tears, symptom such as photophobia, blurred vision, and people can only adopt collyrium to be used for alleviating usually, but collyrium is short action time, can not be effective rapidly, and ocular blood circulation and strengthen aspect such as metabolism and also do not have the method that can effectively alleviate.
(3) summary of the invention
The object of the present invention is to provide a kind of reasonable recipe, effect is unique, eyestrain who produces for excess eye-using and dry and astringent, disease such as itch, and effect is significantly effectively alleviated the eyestrain, promotes the ocular blood circulation, strengthens a metabolic health care subsides.
The object of the present invention is achieved like this: its prescription by weight by: Flos Chrysanthemi 1-6g, Radix Paeoniae Alba 1-6g, tea 1-5g, Margarita 0.5-4g, Radix Angelicae Dahuricae 0.5-3g, Cortex Phellodendri 0.5-4g, Fructus Jujubae 0.5-5g, Flos Carthami 0.5-4g, Rhizoma Chuanxiong 1-6g, Concha Haliotidis 0.5-4g, Radix Glycyrrhizae 0.5-4g, Borax 0.5-3g, Borneolum Syntheticum 0.5-3g, Mentholum 0.5-3g, propylene glycol 2-8g and glycerol 2-8g form.
The present invention at first is broken into powder with Margarita with 16 flavor composition reasonable disposition, and Borneolum Syntheticum, Mentholum are added dissolve with ethanol, Flos Chrysanthemi, the Radix Paeoniae Alba, tea, the Radix Angelicae Dahuricae, Cortex Phellodendri, Fructus Jujubae, Flos Carthami, Rhizoma Chuanxiong, Concha Haliotidis and Radix Glycyrrhizae powder are broken into coarse powder, add 10 times of amount distilled water, soak 2 hours, filter, the medicinal residues squeezing, filtrate concentrates, Borneolum Syntheticum after same again Margarita powder, the dissolving and Mentholum are together, add propylene glycol and glycerol and stir, the raw material immersion is soaked into solution with non-woven fabrics, the pack, seal finished product.
The present invention is the eye external use plaster, the effect of being characterized in directly, by the administration of circumference of eyes meridians and work.The present invention is at first according to eye structure and meridians branch characteristics, according to the research of theory of Chinese medical science scientific composition; Utilize modern science and technology to carry out technical study, high-caliber target level of product quality is set up in research simultaneously, carries out the stability study of product, guarantees product quality.
According to related item regulation of Pharmacopoeia of the People's Republic of China version in 2000: Flos Chrysanthemi, the Radix Paeoniae Alba be monarch drug altogether, and Flos Chrysanthemi has the effect that diffusing wind heat clearing away, suppressing the hyperactive liver make eye bright, and it is dizzy to can be used for having a headache, conjunctival congestion and swelling pain, the dim-sighted grade of eye disease; The Radix Paeoniae Alba has the suppressing the hyperactive liver pain relieving, the effect of the spasmolytic that nourishes blood, and is used to the diseases such as dizzy, blood deficiency and yellow complexion of having a headache.Local topical of the present invention is around eye, and two medicines share to be got its suppressing the hyperactive liver and make eye bright, the merit of relieving spasm to stop pain, and for excess eye-using fatigue, it is dizzy to have a headache, and conjunctival congestion and swelling pain etc. have the alleviation restitution.Help simultaneously with 12 flavor medicines such as Borneolum Syntheticums, be total to the power of principal drug assistance, the refreshment of having one's ideas straightened out simultaneously, heat clearing and blood circulation promoting, the nerve of releiving.Play the eye protection refreshment altogether, the effect of dredge the meridian passage.Rhizoma Chuanxiong has blood-activating and qi-promoting, the effect of wind-expelling pain-stopping, and the Radix Angelicae Dahuricae can heat-clearing and toxic substances removing, has beautification function; The Cortex Phellodendri heat clearing and damp drying, eliminating fire and detoxication, clearind deficient heat; The Flos Carthami promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing; Margarita has beauty treatment, wrinkle removal, antiinflammatory, sterilization, antipruritic, effects such as eyesight-improving and pain-alleviating and convergence granulation promoting, blood circulation promoting, heat-clearing and toxic substances removing; Radix Glycyrrhizae can invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, relieving spasm to stop pain; Borax has the effect of clearing heat for detumescence, removing pathogenic heat from blood and toxic substance from the body, expelling pus and promoting granulation; Borneolum Syntheticum can lead to all keys, the stagnated fire of loosing, and removing nebula makes eye bright, reducing swelling and alleviating pain; Mentholum can have one's ideas straightened out calm the nerves, clearing summer heat, detoxifcation ward off dirty; And Fructus Jujubae has antiallergic, mind tranquilizing and the heart calming, the effect of brain healthy; Tea make eye bright heat clearing away, relieve summer heat, detoxifcation, inhibiting bacteria and diminishing inflammation radioprotective.
Through facts have proved, eye of the present invention pastes reasonable recipe, and effect is unique, eyestrain who produces for excess eye-using and dry and astringent, disease such as itch, and effect is significantly effectively alleviated the eyestrain, promotes the ocular blood circulation, strengthens metabolism.The eyes that cause for various oculopathy are dry and astringent, itch, pain, swelling, shed tears, symptom such as photophobia, blurred vision, have significant improvement effect and therapeutical effect.Obviously reliable to eye health protection, alleviation eyestrain and metabolism effect, long action time has no side effect.The present invention is high in technological content, can improve the eyestrain, safety, efficient, stable.
The eye of making according to prescription of the present invention pastes through Heilongjiang Province's public health monitoring inspection center check and enforcement function test, 60 routine asthenopia experimenter human body result on trial through medical fitness show that the obvious improvement of 30 people's asthenopia symptoms that trial edition invention eye pastes has significance (p＜0.01) with 30 people's comparing differences of matched group.Be subjected to the examination include in standard comprise have ophthalmalgia, eye is dry and astringent, look thing ophthalmic bloated, fatiguability, blurred vision, during the subject perception asthenopia an amount of eye of the present invention being attached to eye takes off after about 20 minutes, test group improvement rate reaches 93.3% after tested, ophthalmalgia doing well,improving rate is reached 70.0%, ophthalmic bloated doing well,improving rate reaches 75.0%, the dry and astringent doing well,improving rate of eye reaches 40.0%, fatiguability doing well,improving rate reaches 92.0%, blurred vision doing well,improving rate reaches 50.0%, illustrates that eye subsides of the present invention have the function of improving the asthenopia symptom.Monitor the inspection center survey report with 2 parts of Heilongjiang Province's public health behind the present patent application file.
(4) specific embodiment
The present invention is described further below in conjunction with specific embodiment:
Embodiment 1:
The prescription of present embodiment by weight by: Flos Chrysanthemi 3g, Radix Paeoniae Alba 3g, tea 2g, Margarita 1g, Radix Angelicae Dahuricae 1g, Cortex Phellodendri 1.5g, Fructus Jujubae 2g, Flos Carthami 1g, Rhizoma Chuanxiong 2g, Concha Haliotidis 1.5g, Radix Glycyrrhizae 1g, Borax 1g, Borneolum Syntheticum 0.5g, Mentholum 0.5g, propylene glycol 5g and glycerol 5g form.
At first Margarita is broken into powder during the present embodiment configuration, Borneolum Syntheticum, Mentholum are added the 20ml dissolve with ethanol, Flos Chrysanthemi, the Radix Paeoniae Alba, tea, the Radix Angelicae Dahuricae, Cortex Phellodendri, Fructus Jujubae, Flos Carthami, Rhizoma Chuanxiong, Concha Haliotidis and Radix Glycyrrhizae powder are broken into coarse powder, add 10 times of amount distilled water, soaked 2 hours, filter, the medicinal residues squeezing, filtrate concentrates approximately to 1000ml, and Borneolum Syntheticum after same again Margarita powder, the dissolving and Mentholum add propylene glycol and glycerol and stir together, the raw material immersion, non-woven fabrics is soaked into solution, the pack, seal finished product.Wherein every subsides contain feed liquid 1g (about 1ml), and every bag 2 is pasted.
Embodiment 2:
The prescription of present embodiment by weight by: Flos Chrysanthemi 5g, Radix Paeoniae Alba 5g, tea 1g, Margarita 2g, Radix Angelicae Dahuricae 0.5g, Cortex Phellodendri 1g, Fructus Jujubae 3g, Flos Carthami 0.5g, Rhizoma Chuanxiong 1g, Concha Haliotidis 1g, Radix Glycyrrhizae 1.5g, Borax 0.5g, Borneolum Syntheticum 0.5g, Mentholum 0.5g, propylene glycol 4g and glycerol 4g form.
The collocation method of present embodiment is with embodiment 1.
Embodiment 3:
The prescription of present embodiment by weight by: Flos Chrysanthemi 3g, Radix Paeoniae Alba 3g, tea 5g, Margarita 2g, Radix Angelicae Dahuricae 2g, Cortex Phellodendri 0.5g, Fructus Jujubae 3g, Flos Carthami 0.5g, Rhizoma Chuanxiong 1g, Concha Haliotidis 0.5g, Radix Glycyrrhizae 1g, Borax 0.5g, Borneolum Syntheticum 1g, Mentholum 0.5g, propylene glycol 4g and glycerol 5g form.
The collocation method of present embodiment is with embodiment 1.
Embodiment 4:
The prescription of present embodiment by weight by: Flos Chrysanthemi 4g, Radix Paeoniae Alba 4g, tea 1.5g, Margarita 1.5g, Radix Angelicae Dahuricae 0.5g, Cortex Phellodendri 0.5g, Fructus Jujubae 5g, Flos Carthami 4g, Rhizoma Chuanxiong 1.5g, Concha Haliotidis 1g, Radix Glycyrrhizae 1g, Borax 0.5g, Borneolum Syntheticum 0.5g, Mentholum 0.5g, propylene glycol 6g and glycerol 4g form.
The collocation method of present embodiment is with embodiment 1.
Claims (1)
1, a kind of health care eye pastes, the prescription that it is characterized in that it by weight by: Flos Chrysanthemi 1-6g, Radix Paeoniae Alba 1-6g, tea 1-5g, Margarita 0.5-4g, Radix Angelicae Dahuricae 0.5-3g, Cortex Phellodendri 0.5-4g, Fructus Jujubae 0.5-5g, Flos Carthami 0.5-4g, Rhizoma Chuanxiong 1-6g, Concha Haliotidis 0.5-4g, Radix Glycyrrhizae 0.5-4g, Borax 0.5-3g, Borneolum Syntheticum 0.5-3g, Mentholum 0.5-3g, propylene glycol 2-8g and glycerol 2-8g form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100726386A CN100571737C (en) | 2007-08-09 | 2007-08-09 | A kind of health care eye pastes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100726386A CN100571737C (en) | 2007-08-09 | 2007-08-09 | A kind of health care eye pastes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101129619A CN101129619A (en) | 2008-02-27 |
| CN100571737C true CN100571737C (en) | 2009-12-23 |
Family
ID=39127131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2007100726386A Active CN100571737C (en) | 2007-08-09 | 2007-08-09 | A kind of health care eye pastes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100571737C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9168220B2 (en) | 2010-06-12 | 2015-10-27 | Mayinglong Pharmaceutical Group Co., Ltd | Eye cream and preparation method |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102319198B (en) * | 2011-08-12 | 2013-02-13 | 马应龙药业集团股份有限公司 | Whitening eye plaster and preparation method thereof |
| CN102319197A (en) * | 2011-08-12 | 2012-01-18 | 马应龙药业集团股份有限公司 | Wrinkle-removal eye paste and preparation method thereof |
| CN103385938B (en) * | 2013-08-01 | 2014-08-06 | 董金兰 | Medicament for eye care |
| CN103536686B (en) * | 2013-10-22 | 2016-08-17 | 洪其镇 | Pharmaceutical composition and preparation method thereof and the patch of the medicament for the eyes containing this pharmaceutical composition |
| CN104984158B (en) * | 2015-06-02 | 2018-08-24 | 华北制药秦皇岛有限公司 | A kind of eye sticker and its preparation process |
| CN105168984A (en) * | 2015-11-03 | 2015-12-23 | 徐冰娜 | Chinese herbal compound eye plaster for treating ophthalmic diseases |
| CN106389775A (en) * | 2016-11-28 | 2017-02-15 | 湖北鼎艾科技有限公司 | Crossostephium leaf cold compressing eye mask |
| CN109303806A (en) * | 2017-07-29 | 2019-02-05 | 誉康健康管理（昆山）有限公司 | A kind of eye cold compress acupoint plaster to promote blood circulation |
| CN110393623A (en) * | 2019-07-25 | 2019-11-01 | 北京爽视医疗器械有限公司 | Eye ice Shu Yi device |
| CN112370523A (en) * | 2020-12-17 | 2021-02-19 | 徐州市乙文中医研究院 | A pharmaceutical composition and paste for preventing and treating asthenopia and myopia |
-
2007
- 2007-08-09 CN CNB2007100726386A patent/CN100571737C/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9168220B2 (en) | 2010-06-12 | 2015-10-27 | Mayinglong Pharmaceutical Group Co., Ltd | Eye cream and preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101129619A (en) | 2008-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100571737C (en) | A kind of health care eye pastes | |
| CN102813839B (en) | Compound medicine for treating cluster headache syndrome | |
| CN100459958C (en) | Chinese medicine heat therapy eyeshade and its medicine | |
| CN102228581B (en) | Chinese herbal medicine for treating rhinitis | |
| CN1058893C (en) | Medicine for treating woman's dysmenorrhea and preparing process thereof | |
| CN101474361A (en) | Chinese medicine for treating cerebropathy | |
| CN103520548B (en) | One improves asthenopia pharmaceutical composition and preparation method thereof | |
| CN102793888A (en) | Chinese medicinal composition for treating scapulohumeral periarthritis | |
| CN101926890B (en) | Medicament for treating xerophthalmia | |
| CN110448618A (en) | A kind of Chinese medicine preparation and preparation method thereof for treating eyesight | |
| CN103239625A (en) | Traditional Chinese medicinal preparation for treating facial paralysis | |
| CN107213100A (en) | Nine taste cleawhite pack and preparation method thereof and application method | |
| CN103405637B (en) | Drug for treating neurosis and preparation method thereof | |
| CN102125643A (en) | Traditional Chinese medicinal capsules for treating headache | |
| CN108498615A (en) | A kind of Chinese herb medicine eye health-care patch and preparation method thereof improving eyes based on nitric oxide principle | |
| CN112263389B (en) | Ophthalmic medicinal moxibustion plaster | |
| CN103536885A (en) | Traditional Chinese medicament for treating kidney deficiency type tinnitus | |
| CN115350230B (en) | Prescription and preparation for preventing myopia | |
| CN118001317A (en) | Externally applied traditional Chinese medicine and eye patch for treating fundus macular degeneration and preparation method thereof | |
| CN103230540B (en) | Plaster for treating facial paralysis and preparation method thereof | |
| CN102068562A (en) | Formula of Chinese medicine for removing ephelis | |
| CN201147570Y (en) | Face mask for curing head diseases | |
| CN104013940A (en) | Traditional Chinese medicine for fumigation foot bath to treat insomnia | |
| CN104435343A (en) | Medicine for improving vision and preparation method of medicine | |
| CN104189632A (en) | Traditional Chinese medicine prescription for treating periodontal disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HARBIN QUANYI BIOTECHNOLOGY DEVELOPMENT CO.,LTD. Free format text: FORMER OWNER: LIU FUSHENG Effective date: 20100325 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 150001 ROOM 403, NO.172, HUAYUAN STREET, NANGANG DISTRICT, HARBIN CITY, HEILONGJIANG PROVINCE TO: 150086 NO.7, HADA NEW VILLAGE, CABLE STREET, NANGANG DISTRICT, HARBIN CITY |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20100325 Address after: 150086, 7, hada village, cable street, Nangang District, Harbin Patentee after: Harbin hundred million Biotechnology Development Co., Ltd. Address before: 150001, room 172, 403 Garden Street, Nangang District, Heilongjiang, Harbin Patentee before: Liu Fusheng |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160222 Address after: 150001, room 172, 403 Garden Street, Nangang District, Heilongjiang, Harbin Patentee after: Liu Fusheng Address before: 150000, 7, hada village, cable street, Nangang District, Heilongjiang, Harbin Patentee before: Harbin hundred million Biotechnology Development Co., Ltd. |
|
| CB03 | Change of inventor or designer information |
Inventor after: Liu Fusheng Inventor after: Tian Ming Inventor before: Liu Fusheng |
|
| CB03 | Change of inventor or designer information | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20191212 Address after: 1500001 room 402, unit 3, No.172 Huayuan street, Nangang District, Harbin City, Heilongjiang Province Co-patentee after: Liu Mengyang Patentee after: Liu Fusheng Address before: 150001, room 172, 403 Garden Street, Nangang District, Heilongjiang, Harbin Patentee before: Liu Fusheng |
|
| TR01 | Transfer of patent right |